$261.25 +1.70 (%) Pharmacyclics Inc - NASDAQ

May. 22, 2015 | 04:00 PM

Partner Headlines

  1. Benzinga's M&A Chatter for Thursday May 21, 2015

    Benzinga | May. 21, 2015 | 19:08PM EST
  2. Move Over Chip Stocks: Here Are 5 Top Biotechs

    IBD | May. 20, 2015 | 09:34AM EST
  3. Move Aside, Chip Stocks, Biotechs Are Leaders Too

    IBD | May. 20, 2015 | 08:02AM EST
  4. Intercept's NASH Trial Design Irks Investors

    IBD | May. 19, 2015 | 11:36AM EST
  5. AbbVie Floats Mega-Bond Deal For Acquisition Funding

    GuruFocus | May. 8, 2015 | 13:38PM EST
  6. Wall Street's Best and Worst Calls of the First Quarter 2015

    GuruFocus | May. 7, 2015 | 16:03PM EST
  7. Pharmacyclics Posts A Mixed First Quarter Ahead Of Being Acquired By AbbVie

    GuruFocus | May. 7, 2015 | 13:16PM EST
  8. Top Stock Mutual Fund New Buys: CyberArk Software

    IBD | May. 5, 2015 | 18:28PM EST
  9. Pharmacyclics tops EPS views

    IBD | May. 1, 2015 | 18:46PM EST
  10. AbbVie Focusing On Diversification Routes To Put Higher Sales Numbers On The Board

    GuruFocus | Apr. 24, 2015 | 14:05PM EST
  11. Forget Google: 5 Top Stocks With Earnings Thursday

    IBD | Apr. 22, 2015 | 19:31PM EST
  12. Pharmacyclics Shares Fall As Kyle Bass Files Petition To Cancel Patent

    Benzinga | Apr. 20, 2015 | 16:09PM EST
  13. It's A Big Weekend For Biotech

    Benzinga | Apr. 17, 2015 | 16:31PM EST
  14. J&J Earnings Beat Estimates; Guidance Mixed

    IBD | Apr. 14, 2015 | 17:48PM EST
  15. J&J Earnings Beat Estimates; Guidance Mixed

    IBD | Apr. 14, 2015 | 11:12AM EST
  16. Chinese Stocks Lead Stock Market Higher

    IBD | Apr. 13, 2015 | 12:03PM EST
  17. AbbVie Upgraded On $7.8 Billion Imbruvica Potential

    IBD | Apr. 13, 2015 | 11:19AM EST
  18. Top Funds Buying Rackspace, Allergan ogen Idec, Apple

    IBD | Mar. 3, 2015 | 18:50PM EST
  19. Leerink: Pharmacyclics Is Now Worth $240

    Benzinga | Mar. 3, 2015 | 15:33PM EST
  20. Wedbush Downgrades Pharmacyclics To Neutral

    Benzinga | Mar. 3, 2015 | 08:15AM EST
  21. Big Cap 20 Reflecting Market Leadership

    IBD | Mar. 2, 2015 | 18:44PM EST
  22. Weekly Analyst Highlights: Oil, Tesla On Readers' Minds

    Benzinga | Feb. 27, 2015 | 16:49PM EST
  23. In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody

    Benzinga | Feb. 27, 2015 | 14:31PM EST
  24. Benzinga's Top Downgrades

    Benzinga | Feb. 27, 2015 | 09:21AM EST
  25. Credit Suisse Downgrades Pharmacyclics To Neutral

    Benzinga | Feb. 27, 2015 | 08:33AM EST
  26. Credit Suisse Downgrades Pharmacyclics Amid Takeover Rumors

    Benzinga | Feb. 26, 2015 | 10:08AM EST
  27. Benzinga's M&A Chatter for Wednesday February 25, 2015

    Benzinga | Feb. 25, 2015 | 21:26PM EST
  28. Pharmacyclics hits new high

    IBD | Feb. 25, 2015 | 18:51PM EST
  29. Deutsche Bank On Pharmacyclics: 'We Do Not See Much Upside'

    Benzinga | Feb. 25, 2015 | 17:05PM EST
  30. Pharmacyclics Rumor: How Some Wall Street Analysts Are Reacting

    Benzinga | Feb. 25, 2015 | 14:47PM EST
  31. Biotech Pharmacyclics Spikes On Buyout Rumors

    IBD | Feb. 25, 2015 | 14:31PM EST
  32. Biotech Stocks Moving Higher

    Benzinga | Feb. 23, 2015 | 15:35PM EST
  33. Stocks Edge Lower, Oil Falls, But Managed-Care Firms Shine

    IBD | Feb. 23, 2015 | 11:47AM EST
  34. Weekly 52-Week Highs Highlight: DG, AGN, ADSK, AVGO, PCYC

    GuruFocus | Feb. 22, 2015 | 18:55PM EST
  35. Nomura Recap of Stocks to Look Out For

    Benzinga | Feb. 19, 2015 | 20:01PM EST
  36. Analysts Respond To Pharmacyclics' Q4 Results

    Benzinga | Feb. 19, 2015 | 14:25PM EST
  37. Why Today's Stock Market Action Is Encouraging

    IBD | Feb. 19, 2015 | 11:55AM EST
  38. Nomura Upgrades Pharmacyclics, Sees 'Upside' To Stock

    Benzinga | Feb. 19, 2015 | 09:42AM EST
  39. Benzinga's Top Downgrades

    Benzinga | Feb. 19, 2015 | 09:07AM EST
  40. JP Morgan Downgrades Pharmacyclics To Neutral

    Benzinga | Feb. 19, 2015 | 08:16AM EST
  41. Leukemia Drug Boosts Sales

    IBD | Feb. 18, 2015 | 18:22PM EST
  42. Actavis Leads IBD 50 Stocks With Earnings This Week

    IBD | Feb. 14, 2015 | 08:02AM EST
  43. JMP Securities Covers Mostly Good News From Pharma Pending More Visibility

    Benzinga | Feb. 11, 2015 | 07:54AM EST
  44. Regeneron Q4 Sales, 2015 Outlook Upbeat On Eylea

    IBD | Feb. 10, 2015 | 10:30AM EST
  45. Stocks That Battle Cancer Were The Best-Performing Biotechs In January

    Benzinga | Jan. 30, 2015 | 13:03PM EST
  46. IBD 50 Turns In Solid Week As Market Uptrend Resumes

    IBD | Jan. 23, 2015 | 18:34PM EST
  47. 10 Biotech Stories You Might've Missed This Week

    Benzinga | Jan. 15, 2015 | 13:18PM EST
  48. Imbruvica lifts Pharmacyclics

    IBD | Jan. 13, 2015 | 18:51PM EST
  49. Mid-Day Market Update: Pharmacyclics Surges On Strong Preliminary 2014 Results; Fresh Market Shares Slip

    Benzinga | Jan. 13, 2015 | 13:24PM EST
  50. Mid-Morning Market Update: Markets Open Higher; Alcoa Profit Beats Expectations

    Benzinga | Jan. 13, 2015 | 11:30AM EST
Trading Center